ting tumor cell technology (CTC), the research is led by two scientists, Dr. Daniel Haber, of Massachusetts General Hospital Cancer Center, and Dr. Mehmet Toner, of the Center for Bio Micro Electro-Mechanical Systems. Epstein's The-Foundation notes that CTC is still in the early stages. Scientists take a sam

lls. "The CTC-iChip test allows patients to be tested easily, with liquid biopsies, more accurately and in genetic real time as cells evolve," says Mehmet Toner, PhD, Director of BioMicroElectroMechanical Systems at Mass General Hospital and one of the principal designers of the CTC-iChip. The CTC-iChip ca